Pharmacological characterization of α1-adrenoceptor subtypes in the bovine tail artery

被引:2
作者
Ioudina, MV [1 ]
Dyer, DC [1 ]
机构
[1] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA
关键词
D O I
10.1046/j.1365-2885.2002.00414.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to identify the alpha(1)-adrenoreceptor subtypes present in the bovine tail artery which mediate contractions to adrenergic agonists. A61603, an alpha(1A)-selective agonist, was more potent compared with norepinephrine and phenylephrine. The pK(A) value of A61603 was 6.93 +/- 0.19 muM (n = 6). Antagonists, BMY 7378, WB 4101 and 5-methylurapidil, caused a parallel shift to the right of the concentration-response curve to A61603 with pA(2) values of 6.62, 9.27 and 8.86, respectively. Prazosin, BMY 7378 and WB 4101 inhibited phenylephrine induced contraction with pA(2) values of 9.47, 7.17 and 9.73, respectively. The pA(2) values obtained for 5-methylurapidil, WB 4101, BMY 7378 and prazosin against alpha(1)-adrenoceptor agonists were significantly correlated with pK(i) values (Zhu, Zhang & Han, 1997, Eur. J. Pharmacol. 329, 55-61) for the cloned alpha(1a)-adrenoceptor but not with the cloned alpha(1b)- or alpha(1d)-adrenoceptor. BMY 7378, a selective alpha(1D)-adrenoceptor antagonist, was significantly more potent against the nonsubtype selective agonist phenylephrine than to A61603. Chloroethylclonidine (50 muM for 10 min) did not affect contractile responses to A61603, but caused a significant inhibition of contractile responses to phenylephrine. In conclusion, it appears that alpha(1A)- and alpha(1D)-adrenoceptors play a role in adrenergic mediated contraction in the bovine tail artery.
引用
收藏
页码:363 / 369
页数:7
相关论文
共 35 条
[1]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[2]   alpha(1)-adrenoceptor-induced contractility in rat aorta is mediated by the alpha(1D) subtype [J].
Buckner, SA ;
Oheim, KW ;
Morse, PA ;
Knepper, SM ;
Hancock, AA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 297 (03) :241-248
[3]   Subtypes of functional α1- and α2-adrenoceptors [J].
Docherty, JR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 361 (01) :1-15
[4]  
Faber JE, 2001, J PHARMACOL EXP THER, V298, P441
[5]   Pharmacological classification of alpha(1)-adrenoceptors mediating contractions of rabbit isolated ear artery: Comparison with rat isolated thoracic aorta [J].
Fagura, MS ;
Lydford, SJ ;
Dougall, IG .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (02) :247-258
[6]  
Furchgott R.F., 1972, Catecholamines, P283
[7]   COMPARISON OF DISSOCIATION CONSTANTS AND OF RELATIVE EFFICACIES OF SELECTED AGONISTS ACTING ON PARASYMPATHETIC RECEPTORS [J].
FURCHGOTT, RF ;
BURSZTYN, P .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1967, 144 (A2) :882-+
[8]  
FURCHGOTT RF, 1968, J PHARMACOL EXP THER, V163, P98
[9]   ALPHA(1A)-ADRENOCEPTOR-MEDIATED CONTRACTILE RESPONSES OF THE HUMAN VAS-DEFERENS [J].
FURUKAWA, K ;
ROSARIO, DJ ;
SMITH, DJ ;
CHAPPLE, CR ;
UCHIYAMA, T ;
CHESSWILLIAMS, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (01) :1605-1610
[10]   BMY-7378 IS A SELECTIVE ANTAGONIST OF THE D-SUBTYPE OF ALPHA(1)-ADRENOCEPTORS [J].
GOETZ, AS ;
KING, HK ;
WARD, SDC ;
TRUE, TA ;
RIMELE, TJ ;
SAUSSY, DL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 272 (2-3) :R5-R6